Case Report

Spinocerebellar ataxia 17: Inconsistency between phenotype and neuroimage findings Jin Zhang, Weihong Gu, Ying Hao, Yuanyuan Chen Movement Disorder and Neurogenetics Research Center, China-Japan Friendship Hospital, Beijing, People’s Republic China Abstract Spinocerebellar ataxia 17 (SCA17) is an autosomal dominant neurodegenerative disease clinically characterized by the presence of cerebellar ataxia in combination with variable neurological symptoms. Here we report a Chinese SCA17 family which proband’s clinical manifestation was inconsistent with the neuroimage findings.

Key Words Neuroimage, spinocerebellar ataxia 17, TATA-box binding protein gene, trinucleotide repeat For correspondence: Dr. Weihong Gu, Movement Disorder and Neurogenetics Research Center, China-Japan Friendship Hospital,

Yinghua East Street, Chaoyang District, Beijing - 100029, People’s Republic China. E-mail: [email protected] Ann Indian Acad Neurol 2013;16:703-4

Introduction SCA17, a rare neurodegenerative disorder, is caused by a CAG trinucleotide expansion in the gene encoding TATA-box binding protein (TBP), which is a general transcription factor crucial for normal cellular function and development. [1-3] The cardinal features include cerebellar ataxia, cognitive decline, psychiatric symptoms, and Parkinsonism; with frequent occurrence of abnormal movements such as chorea or dystonia.[4] Here, we report a Chinese SCA17 family in which the proband’s clinical manifestation was inconsistent with the neuroimage findings.

Case Report A Chinese family including four affected individuals with ataxia syndrome spanning two generations, whose age of onset ranged from 39 to 55 years. The clinical characteristics were somewhat variable, but all patients showed one or more features of cerebellar ataxia, dysarthria, memory deterioration and character change. The proband, a 41-year-old male, was a bank clerk who initially noticed progressive memory Access this article online Quick Response Code:


DOI: 10.4103/0972-2327.120457

deterioration at age 39 when he could not remember the names of his friends occasionally. And his speech became mildly slurred thereafter. The syndromes developed slowly, but the patient was sensitive to the disease because of his positive family history of ataxia. Then he presented to our outpatient clinic at age 40. His past history was negative for alcoholism and drug poisoning. Neurological examination showed mild ataxia. The score of scale for the assessment and rating of ataxia (SARA) was 4 with abnormalities in four items including stance (1 point), speech disturbance (1 point), finger chase (1 point), and fast alternating hand movements (1 point). He stood in natural position steadily, and also able to stand with feet together without sway. But in tandem, he could not stand for 10 s. During conversation, we found his speech slightly slurring, but easy to understand. For finger chase, he presented with a little bit dysmetria, overshooting target below 2 cm in both sides. He could complete 10 cycles of fast alternating hand movements within 10 s, but slightly irregular in both sides. The minimental state examination (MMSE) was normal. His muscle strength, muscle tones, limb reflexes, sensory perception, and autonomic system were also normal. However, it is very interesting that comparing the mild phenotype, the magnetic resonance imaging (MRI) which was taken 1 year before his first visit showed noticeable cerebellar atrophy with moderate cerebral atrophy [Figure 1]. The pathological CAG triplet repeat expansions of spinocerebellar ataxias (SCAs) including SCA1, SCA2, SCA3, SCA6, SCA7, SCA12, SCA17, and dentatorubral-pallidoluysian atrophy (DRPLA)were analyzed by means of polymerase

Annals of Indian Academy of Neurology, October-December 2013, Vol 16, Issue 4

Zhang, et al.: Inconsistency between phenotype and neuroimage findings

704 a


SCA17 is a very rare disorder and the phenotypic variation is therefore not fully described. Our case contributes to a more detailed characterization of clinical picture seen in the quite early stage of SCA17 and it highlights the need for precise clinical and neuroimaging examinations of the patients. The inconsistency between phenotype and the neuroimage findings of this case might suggest that the mechanism of neural compensation might exist.


Figure 1: MRI scans of the proband. T2-weighted sagittal view (a) and T1-weighted axial view (b) showing marked cerebellar atrophy (arrow) accompanied by moderate cerebral atrophy (arrowhead)

chain reaction (PCR), fragment analysis based on capillary electrophoresis, and clone sequencing. The results showed that the proband carried pathological allele of the TBP gene with 45 CAG repeats and normal allele with 36 repeats.

Discussion SCA17 is a rare neurodegenerative disorder that belongs to the group commonly referred to as ‘polyglutaminopathies’. The normal CAG trinucleotide repeats range from 25 to 42, while observed pathogenic expansions range from 43 to 66.[5] A series of studies indicated the broad clinical spectrum of the disease, which most prevalent abnormalities include cerebellar ataxia and dementia at the onset of the disease.[4] However, reduced penetrance is known for alleles of 43-48 repeats.[6,7] For the case in our study, because of the positive family history, he was quite sensitive to the disease at very early stage and came to our clinic. He just noted mild memory deterioration and speech slurring. The neurological examination based on SARA showed slightly abnormalities. The expanded allele of 45 triplets locates in the intermediate range. However, the MRI showed noticeable cerebellar atrophy with moderate cerebral atrophy. The interest of this case lies in the considerably mild phenotype and intermediate repeat size, which are not in accord with the MRI findings. Normally, for SCA17, the MRI findings seem to be associated with the disease course and the repeat length. After longer durations, the atrophy is always pronounced in the cerebellum.[1] Nielsen et al., reported a patient carrying with 43 CAG repeat presented with rapid cognitive decline, but the MRI scan revealed mild atrophy of the cerebellum.[8] The patients carrying with 55 CAG repeats presented in the third decade with obviously gait ataxia and dementia, whose MRI findings indicated diffuse cortical and cerebellar atrophy.[2] Compared to these affected individuals with full blown disease state, the case had mild phenotype, but the cerebellar atrophy was noticeable.

We thank the patients for their cooperation in this study. This research was supported by the grant from the Ministry of Health Foundation of China and the grant from the National Natural Science Foundation of China.

References 1. Nolte D, Sobanski E, Wissen A, Regula JU, Lichy C, Müller U, et al. Spinocerebellar ataxia type 17 associated with an expansion of 42 glutamine residues in TATA box binding protein gene. J Neurol Neurosurg Psychiatry 2010;81:1396-9. 2. Nakamura K, Jeong SY, Uchihara T, Anno M, Nagashima K, Nagashim T, et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 2001;10:1441-8. 3. Reetz K, Kleiman A, Klein C, Lencer R, Zuehlke C, Brockmann K, et al. CAG repeats determine brain atrophy in spinocerebellar ataxia 17: A VBM Study. PLoS One 2011;6:e15125. 4. Stevanin G, Brice A. Spinocerebellar ataxia17 (SCA17) and Huntington’s disease-like 4 (HDL4). Cerebellum 2008;7:170-8. 5. Chen CM, Lee LC, Soong BW, Fung HC, Hsu WC, Lin PY, et al. SCA17 repeat expansion: Mildly expanded CAG/CAA repeat alleles in neurological disorders and the functional implications. Clin Chim Acta 2010;411:375-80. 6. Zühlke C, Dalski A, Schwinger E, Finckh U. Spinocerebellar ataxia type 17: Report of a family with reduced penetrance of an unstable Gln49 TBP allele, haplotype analysis supporting a founder effect for unstable alleles and comparative analysis of SCA17 genotypes. BMC Med Genet 2005;6:27. 7. Oda M, Maruyama H, Komure O, Morino H, Terasawa H, Izumi Y, et al. Possible reduced penetrance of expansion of 44 to 47 CAG/ CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17. Arch Neurol 2004;61:209-12. 8. Nielsen TT, Mardosiene S, Løkkegaard A, Stokholm J, Ehrenfels S, Bech S, et al. Severe and rapidly progressing cognitive phenotype in a SCA17-family with only marginally expanded CAG/ CAA repeats in the TATA-box binding protein gene: A case report. BMC Neurol 2012;12:73. How to cite this article: Zhang J, Gu W, Hao Y, Chen Y. Spinocerebellar ataxia 17: Inconsistency between phenotype and neuroimage findings. Ann Indian Acad Neurol 2013;16:703-4. Received: 26-03-13, Revised: 21-04-13, Accepted: 18-06-13 Source of Support: Ministry of Health Foundation of China and National Natural Science Foundation of China, Conflict of Interest: Nil

Annals of Indian Academy of Neurology, October-December 2013, Vol 16, Issue 4

Copyright of Annals of Indian Academy of Neurology is the property of Medknow Publications & Media Pvt. Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.

Spinocerebellar ataxia 17: Inconsistency between phenotype and neuroimage findings.

Spinocerebellar ataxia 17 (SCA17) is an autosomal dominant neurodegenerative disease clinically characterized by the presence of cerebellar ataxia in ...
862KB Sizes 1 Downloads 0 Views

Recommend Documents

Trehalose attenuates the gait ataxia and gliosis of spinocerebellar ataxia type 17 mice.
Spinocerebellar ataxia type 17 (SCA17) is caused by CAG/CAA repeat expansion on the gene encoding a general transcription factor, TATA-box-binding protein (TBP). The CAG repeat expansion leads to the reduced solubility of polyglutamine TBP and induce

From mild ataxia to huntington disease phenocopy: the multiple faces of spinocerebellar ataxia 17.
Introduction. Spinocerebellar ataxia 17 (SCA 17) is a rare autosomal dominant cerebellar ataxia (ADCA) caused by a CAG/CAA expansion in the TBP gene, reported from a limited number of countries. It is a very heterogeneous ADCA characterized by ataxia

Parkinsonism in spinocerebellar ataxia.
Spinocerebellar ataxia (SCA) presents heterogeneous clinical phenotypes, and parkinsonism is reported in diverse SCA subtypes. Both levodopa responsive Parkinson disease (PD) like phenotype and atypical parkinsonism have been described especially in

Speech in spinocerebellar ataxia.
Spinocerebellar ataxias (SCAs) are a heterogeneous group of autosomal dominant cerebellar ataxias clinically characterized by progressive ataxia, dysarthria and a range of other concomitant neurological symptoms. Only a few studies include detailed c

Role of glutathione S-transferases in the spinocerebellar ataxia type 2 clinical phenotype.
Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative and incurable hereditary disorder caused by a CAG repeat expansion mutation on ATXN2 gene. The identification of reliable biochemical markers of disease severity is of paramount significance

Decreasing fall risk in spinocerebellar ataxia.
[Purpose] Spinocerebellar ataxia consists of a group of autosomal dominant disorders that cause progressive degeneration, mainly in the cerebellum and its connections. Falls, which are a significant concern of this condition, reduce patients' mobilit

Clinical neurogenetics: autosomal dominant spinocerebellar ataxia.
The autosomal dominant spinocerebellar ataxias are a diverse and clinically heterogeneous group of disorders characterized by degeneration and dysfunction of the cerebellum and its associated pathways. Clinical and diagnostic evaluation can be challe

Spinocerebellar ataxia type 10 in Chinese Han.
Spinocerebellar ataxia type 10 (SCA10; OMIM #603516) is an autosomal dominant cerebellar ataxia with variably associated extracerebellar signs.(1,2) SCA10 is caused by an expanded noncoding pentanucleotide repeat in ATXN10, which normally ranges from

Spinocerebellar ataxia-10 with paranoid schizophrenia.
Spino-cerebellar ataxia type 10 (SCA10) is an autosomal dominant disorder that is characterized by cerebellar ataxia, seizures and nystagmus with a fragmented pursuit. Schizophrenia has been reported with SCAs 1 and 2 yet in SCA 10, psychiatric manif